Healthcare dips 2.2%, but ABT shines with 16.5% FCF margin & 13.2% ROIC at 18.6x P/E.
XRP's price stuck despite key upgrades & SEC clarity. Geopolitics & Clarity Act are wildcards.
LMB's 11.9% revenue growth & 46.5% EPS growth at 17.8x P/E. SEZL's 68.1% revenue growth & 323% EPS growth at 13.6x P/E. ENVA's 23.8% revenue growth & 38% EPS growth at 8.7x P/E.
3M+ eye drops recalled over safety! Investors eye pharma risks & potential impact on healthcare sector valuations.
DASH surges 931% EPS on 22% order growth, trading at 17.8x EV/EBITDA. PCAR & CSCO face revenue dips & lower margins.
MEDP's 26.9% FCF margin & 31.7% EPS growth shine. CCL's 9.5% FCF & low returns raise flags.
BETR jumps 23% on expanded credit facility, betting on e-commerce warehouse demand. Is it a buy?
Sponsored
Must Read